Boothbay Fund Management’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,487
Closed -$22.8K 1629
2024
Q2
$22.8K Hold
6,487
﹤0.01% 1453
2024
Q1
$43.2K Buy
+6,487
New +$52.7K ﹤0.01% 1483
2023
Q4
Sell
-29,295
Closed -$202K 1666
2023
Q3
$202K Sell
29,295
-7,502
-20% -$74.3K ﹤0.01% 1435
2023
Q2
$400K Buy
36,797
+4,619
+14% +$54.7K 0.01% 1194
2023
Q1
$481K Buy
+32,178
New +$694K 0.01% 1273

Other funds holding BMRA

Boothbay Fund Management's BMRA Position: Q3 2024 in Review

Boothbay Fund Management sold out of Biomerica (BMRA) in Q3 2024, closing a stake of 6,487 shares — an estimated $22.8K sold.

Boothbay Fund Management first reported a position in BMRA in Q1 2023 and held it in 5 quarters. The position peaked at $481K in Q1 2023. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.

  • Boothbay Fund Management reported no remaining Biomerica position as of Q3 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 6,487 Biomerica shares in Q3 2024, an estimated $22.8K.
  • Boothbay Fund Management first reported a position in Biomerica in Q1 2023 and held it in 5 quarters.
  • Boothbay Fund Management's Biomerica position peaked at $481K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.

Based on Boothbay Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.